16.12 Medical Technologies Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

16.12 Medical Technologies General Information

Description

Developer of the blood clot finder device designed to monitor and predict a thrombotic event, the cause of stroke, and heart attack in a short period. The company's devices are used to measure platelet activation and fibrin formation in a blood sample, enabling healthcare providers to evaluate the disorder and to monitor the effects of antiplatelet and anticoagulation therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Roveredo 20-B
  • 33170 Pordenone
  • Italy
+39 0434
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Devices and Supplies
Corporate Office
  • Via Roveredo 20-B
  • 33170 Pordenone
  • Italy
+39 0434

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

16.12 Medical Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Generating Revenue
3. Grant 30-Nov-2018 Completed Generating Revenue
2. Grant 20-Jun-2018 $58.4K $1.23M Completed Generating Revenue
1. Angel (individual) 08-May-2012 $1.23M $1.23M Completed Generating Revenue
To view 16.12 Medical Technologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

16.12 Medical Technologies Patents

16.12 Medical Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4016076-A1 Apparatus for the evaluation of blood parameters Inactive 21-Dec-2020
EP-4264259-A1 Method for analyzing individual cells or particulates in blood using fluorescence Pending 21-Dec-2020
WO-2022136961-A1 Method for analyzing individual cells or particulates in blood using fluorescence Inactive 21-Dec-2020
CA-3203051-A1 Method for evaluating blood parameters Pending 21-Dec-2020
EP-4264282-A1 Method for evaluating blood parameters Active 21-Dec-2020 G01N33/86
To view 16.12 Medical Technologies’s complete patent history, request access »

16.12 Medical Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

16.12 Medical Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Union Government
Horizon 2020 Government
Italian Angels for Growth Angel Group Minority
MGH7 Venture Capital Venture Capital Minority
To view 16.12 Medical Technologies’s complete investors history, request access »

16.12 Medical Technologies FAQs

  • When was 16.12 Medical Technologies founded?

    16.12 Medical Technologies was founded in 2005.

  • Where is 16.12 Medical Technologies headquartered?

    16.12 Medical Technologies is headquartered in Pordenone, Italy.

  • What is the size of 16.12 Medical Technologies?

    16.12 Medical Technologies has 6 total employees.

  • What industry is 16.12 Medical Technologies in?

    16.12 Medical Technologies’s primary industry is Diagnostic Equipment.

  • Is 16.12 Medical Technologies a private or public company?

    16.12 Medical Technologies is a Private company.

  • What is 16.12 Medical Technologies’s current revenue?

    The current revenue for 16.12 Medical Technologies is .

  • How much funding has 16.12 Medical Technologies raised over time?

    16.12 Medical Technologies has raised $1.23M.

  • Who are 16.12 Medical Technologies’s investors?

    European Union, Horizon 2020, Italian Angels for Growth, and MGH7 Venture Capital have invested in 16.12 Medical Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process